S-Nitrosothiols: Chemistry, Biochemistry, and Biological Actions

Advances in Pharmacology

Volumn 34, Issue C, 1995, Pages 343-349

  Upchurch, Gilbert R ^a   Welch, George N ^b   Loscalzo, Joseph ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOETHANOL; NERVE PROTEIN; NITRIC OXIDE; NITROSO DERIVATIVE; S NITROSOMERCAPTOETHANOL; S NITROSOTHIOL; S-NITROSOMERCAPTOETHANOL;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; MERCAPTOETHANOL; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITROSO COMPOUNDS; S-NITROSOTHIOLS;

EID: 0029438322     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)61096-0     Document Type: Article

References (31)

1. Freedman, J.E., Welch, G., Loscalzo, J., In vitro and in vivo transfer of nitric oxide from a low-molecular-weight S-nitrosothiol to albumin. Circulation 90 (1994), 1–354.
2. Furchgott, R.F., Zawadzki, J.F., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288 (1980), 373–376.
3. Gaston, B., Reilly, J., Drazen, J., Fackler, J., Ramdev, P., Mullins, M., Sugarbaker, D., Jaraki, O., Singel, D.J., Loscalzo, J., Stamler, J.S., Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 10957–10961.
4. Hoefner, U., Boulanger, C., Vanhoutte, P.M., Proximal and distal dog coronary arteries respond differently to basal EDRF but not to NO. Am. J. Physiol. 256 (1989), H828–H831.
5. Ignarro, L.J., Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65 (1989), 1–21.
6. Ignarro, L.J., Endothelium-derived nitric oxide: Actions and properties. FASEB J. 3 (1989), 31–36.
7. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chaudkuri, G., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 9265–9269.
8. Ignarro, L.J., Byrns, R.E., Buga, G.M., Wood, K.S., Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of the nitric oxide radical. Circ. Res. 61 (1987), 866–877.
9. Karitonov, V.G., Sundquist, A.R., Sharma, V.S., Kinetics of nitric oxide autoxidation in aqueous solution. J. Biol. Chem. 269 (1994), 5881–5883.
10. Keaney, J.F., Stamler, J.S., Scharfstein, J., Folts, J.D., Loscalzo, J., NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin. Res., 40, 1992, 194a.
11. Keaney, J.F., Stamler, J.S., Simon, D.I., Jaraki, O., Loscalzo, J., S-Nitroso-bovine serum albumin: An NO adduct with EDRF-like properties. J. Clin. Invest. 91 (1993), 1582–1589.
12. Kelm, M., Schrader, J., Control of coronary vascular tone by nitric oxide. Circ. Res. 66 (1990), 1561–1567.
13. Kerr, S.W., Buchanan, L.V., Bunting, S., Mathews, W.R., Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor. J. Pharmacol. Exp. Ther. 263 (1992), 285–292.
14. Kowaluk, E.A., Fung, H.L., Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255 (1990), 1256–1264.
15. Lewis, R.S., Deen, W.M., Kinetics of the reaction of nitric oxide with oxygen in aqueous solution. Chem. Res. Toxicol. 7 (1994), 568–574.
16. Lipton, S.A., Choi, Y.-B., Lei, S.Z., Chen, H.-S.V., Loscalzo, J., Stamler, J.S., A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (London) 364 (1993), 626–632.
17. Marks, D.S., Vita, J.A., Keaney, J.F. Jr., Loscalzo, J., Complete inhibition of neointimal hyperplasia following vascular injury by a unique adduct of nitric oxide. Circulation 90 (1994), 1–298.
18. Mathews, W.R., Kerr, S.W., Biological activity of S-nitrosothiols: The role of nitric oxide. J. Pharmacol. Exp. Ther. 267 (1993), 1529–1537.
19. Mellion, B.T., Ignarro, L.J., Ohlstein, E.H., Pontecorvo, E.G., Hyman, A.L., Kadowitz, P.J., Evidence for the inhibitory role of guanosine 3#,5# monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57 (1981), 946–955.
20. Mohr, S., Stamler, J.S., Brüne, B., Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite, and related nitrosating agents. FEBS Lett. 348 (1994), 223–227.
21. Molina, Y., Vedia, L., McDonald, B., Reep, B., Brüne, B., DiSilvio, M., Billiar, T.R., Lapetina, E.G., Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267 (1993), 24929–24932.
22. Myers, P.R., Minor, R.L., Guerra, R., Bates, J.N., Harrison, D.G., Vasorelaxant properties of endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature (London) 345 (1990), 161–163.
23. Palmer, R.M.J., Ferige, A.G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327 (1987), 524–526.
24. Scharfstein, J., Keaney, J.F., Slivka, A., Welch, G., Vita, J.A., Stamler, J.S., Loscalzo, J., In vivo transfer of NO between a plasma protein-bound reservoir and low-molecular-weight thiols. J. Clin. Invest. 94 (1994), 1432–1439.
25. Shikano, K., Ohlstein, E.H., Berkowitz, B.A., Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle. Br. J. Pharmacol. 92 (1987), 483–485.
26. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J., Loscalzo, J., S-Nitrosylation of products with nitric oxide: Synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 444–448.
27. Stamler, J.S., Singel, D.J., Loscalzo, J., Biochemistry of nitric oxide and its redox-activated forms. Science 251 (1992), 1898–1901.
28. Stamler, J.S., Jaraki, O., Osborne, J., Simon, D.I., Keaney, J., Vita, J.A., Singel, D., Valeri, C.R., Loscalzo, J., Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 8087–8091.
29. Stamler, J.S., Simon, D.I., Osborne, J.A., Loscalzo, J., S-Nitrosation of tissue-type plasminogen activator confers upon the enzyme vasodilatory and antiplatelet properties. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 8087–8091.
30. Stamler, J.S., Osborne, J.A., Jaraki, O., Rabbani, L.E., Mullins, M., Singel, D., Loscalzo, J., The adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91 (1993), 308–318.
31. 2 reaction. Chem. Res. Toxicol. 7 (1994), 519–525.